Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

The mechanism of action of interferon-β in relapsing multiple sclerosis.
3D GRASE arterial spin labelling reveals an inverse correlation of cortical perfusion with the white matter lesion volume in MS.
Brain MRI abnormalities in Brazilian patients with neuromyelitis optica.
FTY720 preserved islet β-cell mass by inhibiting apoptosis and increasing survival of β-cells in db/db mice.
Advances in Antioxidative Therapy of Multiple Sclerosis.
A randomized clinical trial of autologous T-cell therapy in multiple sclerosis: subset analysis and implications for trial design.
Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen.
JC virus Reactivation During Prolonged Natalizumab Monotherapy for Multiple Sclerosis.
Long-Term Neurocognitive, Psychosocial, and Magnetic Resonance Imaging Outcomes in Pediatric-Onset Acute Disseminated Encephalomyelitis.
Historical overview of the rationale for the pharmacological use of prolonged-release fampridine in multiple sclerosis.
Ready or not: planning for health declines in couples with advanced multiple sclerosis.
Multiple rodent models and behavioral measures reveal unexpected responses to FTY720 and DMF in experimental autoimmune encephalomyelitis.
Neuroscience. To learn is to myelinate.
Targeting Epstein-Barr virus infection as an intervention against multiple sclerosis.
Disease-specific perception of fracture risk and incident fracture rates: GLOW cohort study.
Merck Serono and Opexa Therapeutics Enter into Option and License Agreement for Development of Tcelna™ (imilecleucel-T) for Treatment of Multiple Sclerosis
Neuron-oligodendrocyte myelination co-culture derived from embryonic rat spinal cord and cerebral cortex.
The cuprizone model: regional heterogeneity of pathology.
[Therapeutic effect of encapsulated into the nanocontainers MBP immunodominant peptides on EAE development in DA rats].
Immunomodulatory therapies delay disease progression in multiple sclerosis.
[Association between polymorphisms of cytokine genes and the rate of multiple sclerosis progression.]
The Immunomodulatory and Neuroprotective Effects of Mesenchymal Stem Cells (MSCs) in Experimental Autoimmune Encephalomyelitis (EAE): A Model of Multiple Sclerosis (MS).
Baseline brain activity changes in patients with clinically isolated syndrome revealed by resting-state functional MRI.
Pattern of Uveitis in an Egyptian Population with Multiple Sclerosis: A Hospital-Based Study.
Allelic combinations of immune-response genes as possible composite markers of IFN-β efficacy in multiple sclerosis patients.

Pages